(Q40571173)

21 September 2017

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation (English)

1 reference

21 September 2017

0 references

Zichen Zhang

1

1 reference

21 September 2017

Guan-Hua Lai

series ordinal

2

1 reference

21 September 2017

Alphonse E Sirica

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

39

1 reference

21 September 2017

4

1 reference

21 September 2017

1028-1037

1 reference

Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines

21 September 2017

1 reference

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents

21 January 2018

1 reference

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

21 January 2018

1 reference

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies

21 January 2018

1 reference

7 January 2021

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

1 reference

7 January 2021

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

1 reference

7 January 2021

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

1 reference

7 January 2021

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

1 reference

7 January 2021

Establishment of a novel rat cholangiocarcinoma cell culture model

1 reference

7 January 2021

Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells

1 reference

7 January 2021

Bile duct epithelial cell culture

1 reference

7 January 2021

Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma

1 reference

7 January 2021

Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

1 reference

7 January 2021

Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib

1 reference

7 January 2021

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

7 January 2021

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

7 January 2021

The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change

1 reference

7 January 2021

The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria

1 reference

7 January 2021

Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition

1 reference

7 January 2021

Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.

1 reference

7 January 2021

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

1 reference

7 January 2021

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20143

1 reference

21 September 2017

1 reference